Locus Pharmaceuticals Taps into IBM s Computing on Demand | GenomeWeb

NEW YORK, Dec. 2 (GenomeWeb News) - Locus Pharmaceuticals will use supercomputing power from IBM's Deep Computing Capacity on Demand center to support its drug discovery and development activities, IBM said today.

Locus will augment its existing 2.3 teraflop supercomputing infrastructure by tapping into an IBM eServer Linux cluster system located at IBM's on-demand center in Poughkeepsie, New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.